Disparities in Cancer Genetic Risk Assessment and Testing
- 1 July 2016
- journal article
- research article
- Published by Oncology Nursing Society (ONS) in Oncology Nursing Forum
- Vol. 43 (4) , 519-523
Abstract
Scientific and technologic advances in genomics have revolutionized genetic counseling and testing, targeted therapy, and cancer screening and prevention. Among younger women, African American and Hispanic women have a higher rate of cancers that are associated with hereditary cancer risk, such as triple-negative breast cancer, which is linked to poorer outcomes. Therefore, genetic testing is particularly important in diverse populations. Unfortunately, all races and ethnic groups are not well represented in current genetic testing practices, leading to disparities in cancer prevention and early detection.Keywords
This publication has 27 references indexed in Scilit:
- Awareness of Cancer Susceptibility Genetic TestingAmerican Journal of Preventive Medicine, 2014
- The Need to Build Trust: A Perspective on Disparities in Genetic TestingGenetic Testing and Molecular Biomarkers, 2013
- Genetics, genomics, and cancer risk assessmentCA: A Cancer Journal for Clinicians, 2011
- Awareness and Preferences Regarding BRCA1/2 Genetic Counseling and Testing Among Latinas and Non‐Latina White Women at Increased Risk for Hereditary Breast and Ovarian CancerJournal of Genetic Counseling, 2011
- Stumbling Blocks on the Path to Personalized Medicine in Breast Cancer: The Case of PARP Inhibitors for BRCA1/2-Associated CancersCancer Discovery, 2011
- Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at riskGenetics in Medicine, 2011
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Disparities in BRCA testing: when insurance coverage is not a barrierThe American Journal of Surgery, 2009
- Disparities in Genetic Testing: Thinking Outside theBRCABoxJournal of Clinical Oncology, 2006
- Racial Differences in the Use of BRCA1/2 Testing Among Women With a Family History of Breast or Ovarian CancerJAMA, 2005